{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:02:31Z","timestamp":1788346951185,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/19663-0"],"award-info":[{"award-number":["2017\/19663-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["309972\/2017-5"],"award-info":[{"award-number":["309972\/2017-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["303068\/2021-3"],"award-info":[{"award-number":["303068\/2021-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.mce.2023.111931","type":"journal-article","created":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T01:16:13Z","timestamp":1681607773000},"page":"111931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma"],"prefix":"10.1016","volume":"570","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7434-5701","authenticated-orcid":false,"given":"Denise Engelbrecht","family":"Zantut-Wittmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icleia Siqueira","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-8819","authenticated-orcid":false,"given":"Ana Carolina","family":"Laus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Antunes","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Aparecida","family":"Moma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Fernandes Ribeiro","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edgia Vera Montali da","family":"Assump\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2023.111931_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anl.2011.07.011","article-title":"BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma","volume":"39","author":"Ahn","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.mce.2023.111931_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/jca.2.193","article-title":"Thyroid cancer: burden of illness and management of disease","volume":"2","author":"Brown","year":"2011","journal-title":"J. Cancer"},{"key":"10.1016\/j.mce.2023.111931_bib3","doi-asserted-by":"crossref","first-page":"32318","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2023.111931_bib4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7150\/thno.50333","article-title":"From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer","volume":"11","author":"D'Andr\u00e9a","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.mce.2023.111931_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/jc.2012-3401","article-title":"Papillary thyroid cancer: time course of recurrences during postsurgery surveillance","volume":"98","author":"Durante","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2023.111931_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41418-018-0225-1","article-title":"Mcl-1 and Bcl-xL are essential for survival of the developing nervous system","volume":"8","author":"Fogarty","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mce.2023.111931_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12022-020-09630-5","article-title":"Programmed death-ligand 1 (PD-L1) is a potential biomarker of disease-free survival in papillary thyroid carcinoma: a systematic review and meta-analysis of PD-L1 immunoexpression in follicular epithelial derived thyroid carcinoma","volume":"31","author":"Girolami","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.mce.2023.111931_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gad.186189.111","article-title":"Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors","volume":"26","author":"Gores","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2023.111931_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mce.2023.111931_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2020.11.036","article-title":"BH3 mimetics potentiate pro-apoptotic activity of encorafenib in BRAFV600E melanoma cells","volume":"499","author":"Hartman","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2023.111931_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American thyroid association management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.mce.2023.111931_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cam4.417","article-title":"BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma","volume":"4","author":"Henke","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.mce.2023.111931_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pharmthera.2019.02.007","article-title":"Recent advances in the development of Mcl-1 inhibitors for cancer therapy","volume":"198","author":"Hird","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mce.2023.111931_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1507\/endocrj.EJ12-0176","article-title":"Improvement of lymph node recurrence rate, but not distant recurrence and carcinoma death rates, in patients with papillary thyroid carcinoma after disease-free survival for 5 years","volume":"59","author":"Ito","year":"2012","journal-title":"Endocr. J."},{"key":"10.1016\/j.mce.2023.111931_bib15","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2023.111931_bib16","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2012-2104","article-title":"BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis","volume":"97","author":"Li","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2023.111931_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2004.06.011","article-title":"Genetic and epigenetic modulation of telomerase activity in development and disease","volume":"340","author":"Liu","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.mce.2023.111931_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2023.111931_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0035-1569363","article-title":"Expression of Mcl-1 and Ki-67 in papillary thyroid carcinomas","volume":"124","author":"Maia","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.mce.2023.111931_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/exd.12254","article-title":"Oncogenic BRAF signaling increases Mcl-1 expression in cutaneous metastatic melanoma","volume":"22","author":"McKee","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.mce.2023.111931_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-016-2027-5","article-title":"In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF (V600E) mutation","volume":"469","author":"Nasirden","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2023.111931_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2023.111931_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mce.2023.111931_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2407-9-387","article-title":"Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations","volume":"9","author":"Preto","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mce.2023.111931_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/cancers13030555","article-title":"PD-L1 is an independent prognostic marker in Middle Eastern PTC and its expression is upregulated by BRAFV600E mutation","volume":"13","author":"Siraj","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mce.2023.111931_bib26","doi-asserted-by":"crossref","first-page":"12606","DOI":"10.1073\/pnas.182407599","article-title":"Telomerase contributes to tumorigenesis by a telomere length-independent mechanism","volume":"99","author":"Stewart","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mce.2023.111931_bib27","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1101\/gad.215855.113","article-title":"Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction","volume":"27","author":"Wang","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.mce.2023.111931_bib28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(13)60109-9","article-title":"Progress in molecular-based management of differentiated thyroid cancer","volume":"381","author":"Xing","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2023.111931_bib29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2023.111931_bib30","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.21037\/gs-22-701","article-title":"Combined expression of the BRAFV600E mutation and PD-L1 in early papillary thyroid carcinoma and its relationship with clinicopathological features and recurrence-a retrospective cohort study","volume":"11","author":"Zhang","year":"2022","journal-title":"Gland Surg."},{"key":"10.1016\/j.mce.2023.111931_bib31","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1541-7786.MCR-09-0304","article-title":"Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation","volume":"7","author":"Zhao","year":"2009","journal-title":"Mol. Cancer Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720723000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720723000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:55:42Z","timestamp":1777550142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720723000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"alternative-id":["S0303720723000825"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2023.111931","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2023.111931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111931"}}